Patterns of Coronary Artery Dominance and Association with Severity of Coronary Artery Disease at a Large Tertiary Care Hospital in Pakistan
DOI:
https://doi.org/10.5195/ijms.2023.1430Keywords:
Coronary Artery Disease, Coronary Angiography, Coronary Circulation, Coronary ArteriesAbstract
Background: In cardiac anatomy, the term "dominance" refers to the supply of the posterior descending artery (PDA). Therefore, the PDA might arise from the left circumflex artery (LCX), the right coronary artery (RCA), or both, resulting in left dominant (LD), right dominant (RD), or co-dominant (CD) anatomy, respectively. Few studies have examined the relationship between coronary dominance and coronary artery disease (CAD) severity. CAD severity is defined as single, double, or triple vessel disease based on degree of stenosis. Our study intends to identify coronary dominance trends in Pakistan and show a correlation between coronary dominance and the severity of CAD.
Methods: Between Jun 17, 2018 and August 4, 2018 data from coronary angiographies of 631 patients at a tertiary care hospital in Pakistan was collected. Patients were classified as LD, RD, or CD as reported in the results of coronary angiograms. We utilized a chi-square and multinomial logistic regression analyses to assess whether a correlation exists between coronary dominance and CAD severity.
Results: Subjects were 78.9% RD, 10.5% LD, and 10.6% CD. A significant relation between dominance and severity of CAD was noted, ꭕ2(8, N=631) = 17.58, p=0.025. Individuals with right dominance had a greater chance of developing triple-vessel disease than single-vessel (p =0.025; OR = 0.451; 95% CI for OR: 0.224–0.906) and two-vessel disease (p = 0.029; OR = 0.471; 95% CI for OR: 0.239–0.926).
Conclusion: In our study, right dominance has a positive correlation with severity of coronary artery disease.
Metrics
References
Joshi SD, Joshi SS, Athavale SA. Origins of the coronary arteries and their significance. Clinics. 2010;65(1):79-84. DOI: https://doi.org/10.1590/S1807-59322010000100012
Zipes DP, Libby P, Bonow RO, Braunwald E. Heart disease: a textbook of cardiovascular medicine. 2004.
Goldberg A, Southern DA, Galbraith PD, Traboulsi M, Knudtson ML, Ghali WA, et al. Coronary dominance and prognosis of patients with acute coronary syndrome. Am Heart J. 2007;154(6):1116-22. DOI: https://doi.org/10.1016/j.ahj.2007.07.041
Angelini P, Velasco JA, Flamm S. Coronary anomalies: incidence, pathophysiology, and clinical relevance. Circulation. 2002;105(20):2449-54. DOI: https://doi.org/10.1161/01.CIR.0000016175.49835.57
Bazzocchi G, Romagnoli A, Sperandio M, Simonetti G. Evaluation with 64-slice CT of the prevalence of coronary artery variants and congenital anomalies: a retrospective study of 3,236 patients. La radiologia medica. 2011;116(5):675-89. DOI: https://doi.org/10.1007/s11547-011-0627-3
Knaapen M, Koch AH, Koch C, Koch KT, Li X, van Rooij PC, et al. Prevalence of left and balanced coronary arterial dominance decreases with increasing age of patients at autopsy. A postmortem coronary angiograms study. Cardiovascular Pathology. 2013;22(1):49-53. DOI: https://doi.org/10.1016/j.carpath.2012.02.012
Shao C, Wang J, Tian J, Tang Y-d. Coronary artery disease: from mechanism to clinical practice. Coronary Artery Disease: Therapeutics and Drug Discovery. 2020:1-36. DOI: https://doi.org/10.1007/978-981-15-2517-9_1
Badimon L, Padró T, Vilahur G. Atherosclerosis, platelets and thrombosis in acute ischaemic heart disease. Eur Heart J Acute Cardiovasc Care. 2012;1(1):60-74. DOI: https://doi.org/10.1177/2048872612441582
Bauersachs R, Zannad F. Rivaroxaban: a new treatment paradigm in the setting of vascular protection? J Thromb Haemost. 2018;118(S 01):S12-22. DOI: https://doi.org/10.1055/s-0038-1636530
Kyu HH, Abate D, Abate KH, Abay SM, Abbafati C, Abbasi N, et al. Global, regional, and national disability-adjusted life-years (DALYs) for 359 diseases and injuries and healthy life expectancy (HALE) for 195 countries and territories, 1990–2017: a systematic analysis for the Global Burden of Disease Study 2017. The Lancet. 2018;392(10159):1859-922. DOI: https://doi.org/10.1016/S0140-6736(18)32335-3
Yan B, Yang J, Fan Y, Zhao B, Ma Q, Yang L, et al. Association of coronary dominance with the severity of coronary artery disease: a cross-sectional study in Shaanxi Province, China. BMJ open. 2018;8(11):e021292. DOI: https://doi.org/10.1136/bmjopen-2017-021292
Peng L, Guo X, Gao Y, Guo Q, Zhang J, Fang B, et al. Impact of right coronary dominance on triple-vessel coronary artery disease: A cross-sectional study. Medicine. 2018;97(32). DOI: https://doi.org/10.1097/MD.0000000000011685
Shahoud JS, Ambalavanan M, Tivakaran VS. Cardiac Dominance. StatPearls. Treasure Island (FL): StatPearls Publishing. Copyright © 2022, StatPearls Publishing LLC.; 2022.
Pelter MM, Al-Zaiti SS, Carey MG. Coronary artery dominance. Am J Crit Care. 2011;20(5):401-2. DOI: https://doi.org/10.4037/ajcc2011734
Rehman M, Hussain J, Ahmad I, Mian FA. Coronary Artery Dominance: What pattern exists in Pakistani Population? Ann Pak Inst Med Sci. 2011;7(1):3-5.
Samoon S, Andrabi SMA, Itoo MS. Pattern of coronary artery dominance in kashmiri population—an angiography study. Int J Sci Res. 2020. DOI: https://doi.org/10.36106/ijsr/2739737
Karna AK, Maskey A, Nepal H, Yadav DN. Study of coronary artery dominance in Nepalese population by angiographic method. Nepalese Heart Journal. 2017;14(2):25-30. DOI: https://doi.org/10.3126/njh.v14i2.18499
Vasheghani‐Farahani A, Kassaian SE, Yaminisharif A, Davoodi G, Salarifar M, Amirzadegan A, et al. The association between coronary arterial dominancy and extent of coronary artery disease in angiography and paraclinical studies. Clin Anat. 2008;21(6):519-23. DOI: https://doi.org/10.1002/ca.20669
Khona P, Ashwini C. A study of coronary dominance in population of North Karnataka. Int J Anat Res. 2018;6(1.3):5030-33. DOI: https://doi.org/10.16965/ijar.2018.104
Hajar R. Risk factors for coronary artery disease: historical perspectives. Heart Views. 2017;18(3):109. DOI: https://doi.org/10.4103/HEARTVIEWS.HEARTVIEWS_106_17
Published
How to Cite
License
Copyright (c) 2023 Ata Ul Haiy, Tehreem, Roshaan, Amna, Amna Kazmi, Arslan, Nasiha
This work is licensed under a Creative Commons Attribution 4.0 International License.
Authors who publish with this journal agree to the following terms:
- The Author retains copyright in the Work, where the term “Work” shall include all digital objects that may result in subsequent electronic publication or distribution.
- Upon acceptance of the Work, the author shall grant to the Publisher the right of first publication of the Work.
- The Author shall grant to the Publisher and its agents the nonexclusive perpetual right and license to publish, archive, and make accessible the Work in whole or in part in all forms of media now or hereafter known under a Creative Commons Attribution 4.0 International License or its equivalent, which, for the avoidance of doubt, allows others to copy, distribute, and transmit the Work under the following conditions:
- Attribution—other users must attribute the Work in the manner specified by the author as indicated on the journal Web site; with the understanding that the above condition can be waived with permission from the Author and that where the Work or any of its elements is in the public domain under applicable law, that status is in no way affected by the license.
- The Author is able to enter into separate, additional contractual arrangements for the nonexclusive distribution of the journal's published version of the Work (e.g., post it to an institutional repository or publish it in a book), as long as there is provided in the document an acknowledgment of its initial publication in this journal.
- Authors are permitted and encouraged to post online a prepublication manuscript (but not the Publisher’s final formatted PDF version of the Work) in institutional repositories or on their Websites prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work. Any such posting made before acceptance and publication of the Work shall be updated upon publication to include a reference to the Publisher-assigned DOI (Digital Object Identifier) and a link to the online abstract for the final published Work in the Journal.
- Upon Publisher’s request, the Author agrees to furnish promptly to Publisher, at the Author’s own expense, written evidence of the permissions, licenses, and consents for use of third-party material included within the Work, except as determined by Publisher to be covered by the principles of Fair Use.
- The Author represents and warrants that:
- the Work is the Author’s original work;
- the Author has not transferred, and will not transfer, exclusive rights in the Work to any third party;
- the Work is not pending review or under consideration by another publisher;
- the Work has not previously been published;
- the Work contains no misrepresentation or infringement of the Work or property of other authors or third parties; and
- the Work contains no libel, invasion of privacy, or other unlawful matter.
- The Author agrees to indemnify and hold Publisher harmless from the Author’s breach of the representations and warranties contained in Paragraph 6 above, as well as any claim or proceeding relating to Publisher’s use and publication of any content contained in the Work, including third-party content.
Enforcement of copyright
The IJMS takes the protection of copyright very seriously.
If the IJMS discovers that you have used its copyright materials in contravention of the license above, the IJMS may bring legal proceedings against you seeking reparation and an injunction to stop you using those materials. You could also be ordered to pay legal costs.
If you become aware of any use of the IJMS' copyright materials that contravenes or may contravene the license above, please report this by email to contact@ijms.org
Infringing material
If you become aware of any material on the website that you believe infringes your or any other person's copyright, please report this by email to contact@ijms.org
